Cheerland Biomedicine (CLBiomed) aims to build a world-class biotech enterprise, offering a wide array of products and services, ranging from Bio-CDMO, molecular diagnostics, cell therapeutics, and healthcare services. Bio-CDMO is our main focus as we are building the largest biologics development and manufacturing site in the world, serving global biopharma companies.
With a total planned capacity over 1.3ML and maximal bioreactor size at 20KL, and led by a world-class management team, we are building the largest Biologics CDMO platform, providing high-quality, affordable and trusted Bio-CDMO services to global biotech companies.
Based on the powerful NGS platform and IVD kits developed in-house, we provide molecular diagnostic testing services for cancer and reproductive patients. We also provide consumer genomics products to people who are interested in their “book of life” and genetics-based preventative medicine and health management.
We are building an ecosystem of healthcare solutions and services, in our elder-care, rehabilitation projects in several strategically located sites near Beijing, Shanghai and Shenzhen. We provide a full range of services covering molecular diagnostics, disease prevention, chronic disease management, stem cell therapy, and other advanced services.
Headquartered in Shenzhen, currently CLBiomed has subsidiaries, branches, and/or medical diagnostic labs in Beijing, Langfang, Shanghai, Wuhan, Chengdu as well as other cities in China, and investment arms in New York and Silicon Valley in the US.
Build a world-class biotechnology enterprise.
We are Cheerland, the Land of Curing and Caring.
Create real values, customers above all;
Strive for success, never seek excuses;
Achieve more through diligence and teamwork;
Think long term, act now.